EX-99.1 2 ex991october2026.htm EX-99.1 Document

Exhibit 99.1
TITAN INTERNATIONAL, INC.
Unaudited Condensed Consolidated Statements of Operations
Recast for Discontinued Operations
(All amounts in thousands, except per share data)
Three months ended
June 30, 2026
March 31, 2026
June 30, 2025
March 31, 2025
Net sales
$
366,290 
$
395,153 
$
344,557 
$
384,956 
Cost of sales
309,522 
337,078 
292,034 
329,458 
Gross profit
56,768 
58,075 
52,523 
55,498 
Selling, general, and administrative expenses
44,558 
44,235 
44,968 
42,984 
Research and development expenses
3,711 
3,159 
2,805 
2,830 
Royalty expense
2,653 
2,410 
2,419 
2,446 
Restructuring and other charges
834 
25,142 
— 
— 
Income (loss) from operations
5,012 
(16,871)
2,331 
7,238 
Interest expense
(10,054)
(9,887)
(9,674)
(9,534)
Interest income
2,317 
1,898 
2,094 
1,950 
Foreign exchange loss
(75)
(321)
(1,969)
(819)
Other income
506 
756 
993 
697 
Loss from continuing operations before income taxes
(2,294)
(24,425)
(6,225)
(468)
(Benefit) provision for income taxes
(1,032)
3,304 
621 
3,368 
Net loss from continuing operations
(1,262)
(27,729)
(6,846)
(3,836)
Net income from discontinued operations, net of tax
7,602 
3,479 
3,242 
3,858 
Net income (loss)
6,340 
(24,250)
(3,604)
22 
Net income (loss) attributable to noncontrolling interests
576 
(36)
941 
671 
Net income (loss) attributable to Titan and applicable to common shareholders
$
5,764 
$
(24,214)
$
(4,545)
$
(649)
(Loss) earnings per common share:
Basic net loss from continuing operations per share
$
(0.02)
$
(0.43)
$
(0.11)
$
(0.06)
Basic net income (loss) per share attributable to Titan and applicable common stockholders
$
0.09 
$
(0.38)
$
(0.07)
$
(0.01)
Diluted net loss from continuing operations per share
$
(0.02)
$
(0.43)
$
(0.11)
$
(0.06)
Diluted net income (loss) per share attributable to Titan and applicable common stockholders
$
0.09 
$
(0.38)
$
(0.07)
$
(0.01)
Average common shares and equivalents outstanding:
Basic
64,384 
64,072 
63,722 
63,283 
Diluted
64,504 
64,072 
63,722 
63,283 



TITAN INTERNATIONAL, INC.
Unaudited Condensed Consolidated Statements of Cash Flows
Recast for Discontinued Operations
(All amounts in thousands)
Three months ended
Cash flows from operating activities:
June 30, 2026
March 31, 2026
June 30, 2025
March 31, 2025
Net income (loss)
$
6,340 
$
(24,250)
$
(3,604)
$
22 
Net income from discontinued operations, net of tax
7,602 
3,479 
3,242 
3,858 
Net loss from continuing operations
(1,262)
(27,729)
(6,846)
(3,836)
Adjustments to reconcile net loss to net cash provided by operating activities of continuing operations:
Depreciation and amortization
13,702 
13,592 
13,443 
12,868 
Restructuring and other charges
834 
25,142 
— 
— 
Deferred income tax (benefit) provision
(4,838)
1,155 
3,379 
(1,201)
(Gain) loss on fixed asset and investment sale
(20)
64 
(2)
40 
Stock-based compensation
1,221 
565 
1,405 
(925)
Issuance of stock under 401(k) plan
420 
418 
431 
396 
Foreign currency (gain) loss
(1,217)
1,464 
14,367 
3,180 
(Increase) decrease in assets:
Accounts receivable
24,481 
(84,724)
35,047 
(78,735)
Inventories
3,222 
7,736 
(12,895)
(2,318)
Prepaid and other current assets
(1,826)
955 
(2,759)
(359)
Other assets
(2,912)
(3,245)
(2,961)
(1,417)
Increase in liabilities:
Accounts payable
(6,162)
17,671 
(19,760)
39,282 
Other current liabilities
1,986 
5,903 
(9,067)
106 
Other liabilities
2,626 
569 
1,658 
410 
Net cash provided by (used for) operating activities of continuing operations
30,255 
(40,464)
15,440 
(32,509)
Net cash provided by (used for) operating activities of discontinued operations
8,894 
(6,062)
(1,127)
(6,082)
Net cash provided by (used for) operating activities
39,149 
(46,526)
14,313 
(38,591)
Cash flows from investing activities:
Capital expenditures
(8,628)
(10,397)
(8,697)
(13,503)
Proceeds (loss) from sale of fixed assets
843 
(25)
29 
182 
Net cash used for investing activities of continuing operations
(7,785)
(10,422)
(8,668)
(13,321)
Net cash used for investing activities of discontinued operations
(4,081)
(2,712)
(1,350)
(1,507)
Net cash used for investing activities
(11,866)
(13,134)
(10,018)
(14,828)
Cash flows from financing activities:
Proceeds from borrowings
17,362 
57,698 
28,327 
26,604 
Repayments of debt
(35,890)
(32,686)
(29,335)
(6,496)
Other financing activities
(22)
(195)
(133)
98 
Net cash (used for) provided by financing activities of continuing operations
(18,550)
24,817 
(1,141)
20,206 
Net cash (used for) provided by financing activities of discontinued operations
(889)
1,377 
(567)
(1,592)
Net cash (used for) provided by financing activities
(19,439)
26,194 
(1,708)
18,614 
Effect of exchange rate changes on cash
679 
1,849 
7,652 
13,261 
Net increase (decrease) in cash and cash equivalents
8,523 
(31,617)
10,239 
(21,544)
Cash and cash equivalents, beginning of period
171,262 
202,879 
174,430 
195,974 
Cash and cash equivalents, end of period
$
179,785 
$
171,262 
$
184,669 
$
174,430 
Supplemental information:
Interest paid
$
17,260 
$
3,396 
$
17,959 
$
3,209 
Income taxes paid, net of refunds received
4,299 
2,137 
4,714 
3,421 



The table below provides a reconciliation of net loss to EBITDA and adjusted EBITDA, which are non-GAAP financial measures, for the three months ended June 30, 2026, March 31, 2026, June 30, 2025 and March 31, 2025 (in thousands).

Three months ended
June 30, 2026
March 31, 2026
June 30, 2025
March 31, 2025
Net loss from continuing operations
$
(1,262)
$
(27,729)
$
(6,846)
$
(3,836)
Adjustments:
(Benefit) provision for income taxes
(1,032)
3,304 
621 
3,368 
Interest expense, excluding financing fees amortization
9,897 
9,972 
9,759 
9,592 
Depreciation and amortization
13,702 
13,592 
13,443 
12,868 
EBITDA from continuing operations
$
21,305 
$
(861)
$
16,977 
$
21,992 
Adjustments:
Foreign exchange loss
75 
321 
1,969 
819 
Restructuring and impairment expenses
834 
25,142 
— 
— 
Adjusted EBITDA from continuing operations
$
22,214 
$
24,602 
$
18,946 
$
22,811 
Adjusted EBITDA from discontinued operations
11,946 
6,754 
11,213 
8,012 
Adjusted EBITDA attributable to Titan and applicable to common shareholders
$
34,160 
$
31,356 
$
30,159 
$
30,823